IL17A and nasopharyngeal carcinoma: In nasopharyngeal carcinoma (NPC), miR-24-3p is profoundly upregulated in TDEs that can be delivered into T cells, where it then inhibits the percentage of CD4+ T cells and decreases the production of IFN-γ and IL-17 while provoking the augment of CD4+ Foxp3+ T cells (Tregs) (65).